To show that PAT-DX3 can cross the BBB on animal studies hugely derisks the company yet the sp is up only to 2.1c. I realise the DOW tanked and all biotecs are out of favour but we should at least be where we before the delay with the engineering run. Oh well - never argue with the tape!
Ann: PAT DX3 Crosses Blood Brain Barrier in Healthy Animals, page-9
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
-0.001(14.3%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $1.953K | 325.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4291214 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 500160 | 1 |
View Market Depth
| Last trade - 11.14am 06/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |